title: Ranitidine preparations on the Belgian market: a comparative study.
abstract: Ranitidine preparations formulated as tablets and granules were evaluated with different tests including in vitro dissolution and assay. Previously the analytical methods of these tests were validated according to the guidelines of the European network of Official Medicines Control Laboratories (OMCLs). All examined products complied to the requirements as described in the European, the British and the US Pharmacopoeia and consequently they can be considered as pharmaceutically equivalent.
authors.affiliation: Service de Contrôle des Médicaments, rue Stévin 137, B-1000 Bruxelles.
authors.forename: J
authors.initials: J
authors.lastname: Saevels
authors.forename: K
authors.initials: K
authors.lastname: De Braekeleer
authors.forename: J
authors.initials: J
authors.lastname: Corthout
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000592:standards; D001530:Belgium; D002626:Chemistry, Pharmaceutical; D002853:Chromatography, Liquid; D006801:Humans; D004366:Nonprescription Drugs / Q000592:standards; D011786:Quality Control; D011899:Ranitidine / Q000008:administration & dosage* / Q000592:standards; D015203:Reproducibility of Results
chemical_list: D000897:Anti-Ulcer Agents; D004366:Nonprescription Drugs; D011899:Ranitidine